These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12866357)

  • 1. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of low density lipoprotein association with the arterial intima. A possible environment for the antiatherogenic action of beta-blockers.
    Camejo G; Hurt E; Thubrikar M; Bondjers G
    Circulation; 1991 Dec; 84(6 Suppl):VI17-22. PubMed ID: 1683606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oxidized low density lipoprotein in atherogenesis.
    Witztum JL; Steinberg D
    J Clin Invest; 1991 Dec; 88(6):1785-92. PubMed ID: 1752940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structural analysis of the interaction of low density lipoproteins with arterial intima cells in atherosclerosis].
    Bobryshev IuV; Kuznetsov AS
    Arkh Patol; 1989; 51(9):20-6. PubMed ID: 2596978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of oxidation of lipoproteins in the pathogenesis of atherosclerosis].
    Picard S
    Pathol Biol (Paris); 1996 Jan; 44(1):46-50. PubMed ID: 8734300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima.
    Pentikäinen MO; Oörni K; Ala-Korpela M; Kovanen PT
    J Intern Med; 2000 Mar; 247(3):359-70. PubMed ID: 10762453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
    Hurt-Camejo E; Camejo G
    Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low density lipoprotein (LDL) heterogeneity and atherosclerosis].
    Dejager S; Cohen R; Bruckert E
    Ann Biol Clin (Paris); 1990; 48(3):154-60. PubMed ID: 2191608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent data about the LDL-atherogenesis relationship].
    Păduraru I; Hurjui J; Filimon O; Filimon M; Saramet A; Petriş O; Lionte C
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):31-6. PubMed ID: 12092155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein metabolism in arterial walls and its relationship with the genesis of atheromatous lesion].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Scala R; Sifola C; Antignano A
    Clin Ter; 1994 Jan; 144(1):63-72. PubMed ID: 8168354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more.
    Pentikäinen MO; Oksjoki R; Oörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):211-7. PubMed ID: 11834518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
    Dittrich R; Dragonas C; Mueller A; Maltaris T; Rupp J; Beckmann MW; Maass M
    Biochem Biophys Res Commun; 2004 Jun; 319(2):501-5. PubMed ID: 15178434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New discoveries on atherosclerosis. LDL oxidation plays a central role].
    Nilsson J
    Lakartidningen; 1995 Oct; 92(40):3684-6, 3691. PubMed ID: 7564616
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidized low density lipoprotein--an extreme example of lipoprotein heterogeneity.
    Steinberg D
    Isr J Med Sci; 1996 Jun; 32(6):469-72. PubMed ID: 8682653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions.
    Oörni K; Pentikäinen MO; Ala-Korpela M; Kovanen PT
    J Lipid Res; 2000 Nov; 41(11):1703-14. PubMed ID: 11060340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
    Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
    J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular atherosclerosis.
    Moorhead JF; Brunton C; Varghese Z
    Miner Electrolyte Metab; 1997; 23(3-6):287-90. PubMed ID: 9387135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-atherogenic effects of an egg yolk-enriched garlic supplement.
    Yamaji K; Sarker KP; Abeyama K; Maruyama I
    Int J Food Sci Nutr; 2004 Feb; 55(1):61-6. PubMed ID: 14630593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.